Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.48 |
| ▸ | RXRA | P19793 | 2/20 | 0.44 |
| ▸ | RXRB | P28702 | 2/20 | 0.44 |
| ▸ | RXRG | P48443 | 2/20 | 0.44 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | MITF | O75030 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11086986 | 0.85 | BACE1 (0.36) | CA2CAMK2ARXRARXRBRXRG | |
| SCHEMBL2852051 | 0.84 | CYP1A2 (0.48) | RXRBAKR1B1PTGS1NR1H4 | |
| SCHEMBL9435638 | 0.84 | CYP4F2 (0.50) | ALDH1A1LMNAGAAHTTSMN1; SMN2 | |
| SCHEMBL11086982 | 0.83 | BACE1 (0.32) | — | |
| SCHEMBL3722014 | 0.83 | RXRA (0.51) | RXRARXRBRXRGALDH1A1HPGD | |
| SCHEMBL1501623 | 0.82 | L3MBTL1 (0.49) | RXRARXRBRXRGALDH1A1GAA | |
| SCHEMBL6303196 | 0.81 | SMN1; SMN2 (0.54) | RXRARXRBALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL2506528 | 0.81 | SRD5A2 (0.46) | CA2CAMK2ARXRARXRBRXRG | |
| SCHEMBL906834 | 0.80 | IDO1 (0.48) | HSD17B10HPGDLMNATSHR | |
| SCHEMBL10140463 | 0.80 | CYP4F2 (0.40) | ALDH1A1LMNAGAAHTTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4687854-A2 | LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY | Flagship Labs 114, Inc. (US) | 2026-02-11 | — | — | EP | disclosed |
| US-12303510-B2 | Inhibitory effect of low molecular weight compound on cancer and fibrosis | NATIONAL UNIVERSITY CORPORATION TOTTORI UNIVERSITY (JP) | 2025-05-20 | — | — | US | disclosed |
| EP-4452942-A1 | NANOMATERIALS COMPRISING DISULFIDES | Beam Therapeutics Inc. (US) | 2024-10-30 | — | — | EP | disclosed |
| US-20240335542-A1 | NANOMATERIALS COMPRISING DISULFIDES | BEAM THERAPEUTICS INC. | 2024-10-10 | — | — | US | disclosed |
| WO-2024211865-A2 | LIPIDS AND LIPID-LIKE COMPOUNDS FOR THERAPEUTIC LIPID NANOPARTICLE (LNP) DELIVERY | OMEGA THERAPEUTICS, INC. (US) | 2024-10-10 | — | — | WO | disclosed |
| WO-2023121964-A1 | NANOMATERIALS COMPRISING DISULFIDES | BEAM THERAPEUTICS INC. (US) | 2023-06-29 | — | — | WO | disclosed |
| WO-2023121964-A1 | NANOMATERIALS COMPRISING DISULFIDES | BEAM THERAPEUTICS INC. (US) | 2023-06-29 | — | — | WO | disclosed |
| US-11213527-B2 | Inhibitory effect of low molecular weight compound on cancer and fibrosis | NATIONAL UNIVERSITY CORPORATION TOTTORI UNIVERSITY (JP) | 2022-01-04 | — | — | US | disclosed |
| US-20210386747-A1 | INHIBITORY EFFECT OF LOW MOLECULAR WEIGHT COMPOUND ON CANCER AND FIBROSIS | KANONCURE, INC. (JP) | 2021-12-16 | — | — | US | disclosed |
| CN-108026104-B | Cancer and fibrosis inhibition and regeneration promotion effects using low-molecular-weight compound | 国立大学法人鸟取大学 | 2021-06-18 | — | — | CN | disclosed |
| US-20190055249-A1 | SUPPRESSION AND REGENERATION PROMOTING EFFECT OF LOW MOLECULAR WEIGHT COMPOUND ON CANCER AND FIBROSIS | NATIONAL UNIVERSITY CORPORATION TOTTORI UNIVERSITY (JP) | 2019-02-21 | — | — | US | disclosed |
| EP-3366687-A1 | SUPPRESSION AND REGENERATION PROMOTING EFFECT OF LOW MOLECULAR WEIGHT COMPOUND ON CANCER AND FIBROSIS | National University Corporation Tottori University (JP) | 2018-08-29 | — | — | EP | disclosed |
| CN-108026104-A | The suppression of cancer and fibrosis and the effect of regeneration promotion using low molecular compound | 国立大学法人鸟取大学 | 2018-05-11 | — | — | CN | disclosed |
| US-20180028536-A1 | INHIBITORY EFFECT OF LOW MOLECULAR WEIGHT COMPOUND ON CANCER AND FIBROSIS | KANONCURE, INC. (JP) | 2018-02-01 | — | — | US | disclosed |
| US-9650414-B1 | Dual-action EP4 agonist—bisphosphonate conjugates and uses thereof | SIMON FRASER UNIVERSITY (CA) | 2017-05-16 | — | — | US | disclosed |
| US-9650414-B1 | Dual-action EP4 agonist—bisphosphonate conjugates and uses thereof | SIMON FRASER UNIVERSITY (CA) | 2017-05-16 | — | — | US | disclosed |
| EP-3150207-A1 | INHIBITORY EFFECT OF LOW MOLECULAR WEIGHT COMPOUND ON CANCER AND FIBROSIS | National University Corporation Tottori University (JP) | 2017-04-05 | — | — | EP | disclosed |
| CN-106132417-A | Cancer and fibrosis inhibiting effects of low molecular weight compound | 国立大学法人鸟取大学 | 2016-11-16 | — | — | CN | disclosed |
| WO-2015147107-A1 | INHIBITORY EFFECT OF LOW MOLECULAR WEIGHT COMPOUND ON CANCER AND FIBROSIS | 国立大学法人鳥取大学 | 2015-10-01 | — | — | WO | disclosed |
| EP-1916239-A1 | PYRIDONE COMPOUND | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2008-04-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12303510-B2 | Inhibitory effect of low molecular weight compound on cancer and fibrosis | MMP1, SERPINB1, LGALS1 | CA2 3267/4885CAMK2A 3132/4885RXRA 2022/4885 |
| US-20240335542-A1 | NANOMATERIALS COMPRISING DISULFIDES | GPX4, GPX1, ABCB7 | CA2 4205/4885CAMK2A 3892/4885RXRA 1441/4885 |
| US-20190055249-A1 | SUPPRESSION AND REGENERATION PROMOTING EFFECT OF LOW MOLECULAR WEIGHT COMPOUND ON CANCER AND FIBROSIS | HDGF, SHC1, HGF | CA2 4044/4885CAMK2A 1386/4885RXRA 961/4885 |
| US-11213527-B2 | Inhibitory effect of low molecular weight compound on cancer and fibrosis | MMP1, SERPINB1, LGALS1 | CA2 3267/4885CAMK2A 3132/4885RXRA 2022/4885 |
| US-20210386747-A1 | INHIBITORY EFFECT OF LOW MOLECULAR WEIGHT COMPOUND ON CANCER AND FIBROSIS | MMP1, SERPINB1, LGALS1 | CA2 3267/4885CAMK2A 3132/4885RXRA 2022/4885 |
| US-20180028536-A1 | INHIBITORY EFFECT OF LOW MOLECULAR WEIGHT COMPOUND ON CANCER AND FIBROSIS | MMP1, SERPINB1, LGALS1 | CA2 3267/4885CAMK2A 3132/4885RXRA 2022/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.